Pemetrexed Fresenius Kabi European Union - English - EMA (European Medicines Agency)

pemetrexed fresenius kabi

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Ciprofloxacin Kabi 200 mg/100 ml solution for infusion Malta - English - Medicines Authority

ciprofloxacin kabi 200 mg/100 ml solution for infusion

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for infusion - ciprofloxacin 2 mg/ml - antibacterials for systemic use

Ciprofloxacin Kabi 400 mg/200 ml solution for infusion Malta - English - Medicines Authority

ciprofloxacin kabi 400 mg/200 ml solution for infusion

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for infusion - ciprofloxacin 2 mg/ml - antibacterials for systemic use

Ondansetron Kabi 0.08 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ondansetron kabi 0.08 mg/ml solution for infusion

fresenius kabi deutschland gmbh - ondansetron hydrochloride dihydrate - solution for infusion - ondansetron

Ondansetron Kabi 0.16 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ondansetron kabi 0.16 mg/ml solution for infusion

fresenius kabi deutschland gmbh - ondansetron hydrochloride dihydrate - solution for infusion - ondansetron

Fluconazole Kabi 2mg/ml solution for infusion - 50ml Malta - English - Medicines Authority

fluconazole kabi 2mg/ml solution for infusion - 50ml

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for infusion - fluconazole 2 mg/ml - antimycotics for systemic use

Fluconazole Kabi 2mg/ml solution for infusion - 100ml Malta - English - Medicines Authority

fluconazole kabi 2mg/ml solution for infusion - 100ml

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for infusion - fluconazole 2 mg/ml - antimycotics for systemic use

Fluconazole Kabi 2mg/ml solution for infusion - 200ml Malta - English - Medicines Authority

fluconazole kabi 2mg/ml solution for infusion - 200ml

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - solution for infusion - fluconazole 2 mg/ml - antimycotics for systemic use